List of works - Margareta Reis

Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study

scientific article published on 19 February 2013

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

scientific article

Drug use in pregnant women-a pilot study of the coherence between reported use of drugs and presence of drugs in plasma.

scientific article published on 20 December 2017

Easier for students to reproduce facts than to draw their own conclusions

scientific article published in November 2013

Enantioselective analysis of citalopram and metabolites in adolescents.

scientific article published in December 2001

Maternal use of antipsychotics in early pregnancy and delivery outcome.

scientific article

Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy

scientific article published on 01 October 2012

Partial Compliance as Determined From Plasma Levels of Sertraline and Its Metabolite in Depressed Patients in Primary Care ⬇️

scientific article published on December 1, 2010

Sedative and hypnotic drugs—Fatal and non-fatal reference blood concentrations

scientific article published on 13 January 2014

Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression.

scientific article

Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting.

scientific article published in August 2002

Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.

scientific article

The use of central nervous system active drugs during pregnancy

scientific article published on 10 October 2013

Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.

scientific article published in April 2003

Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients

scientific article published on 01 May 2000

Therapeutic drug monitoring of sertraline: variability factors as displayed in a clinical setting

scientific article published on 01 August 2000

Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.

scientific article

List of works by Margareta Reis

Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

Drug use in pregnant women-a pilot study of the coherence between reported use of drugs and presence of drugs in plasma.

Easier for students to reproduce facts than to draw their own conclusions

Enantioselective analysis of citalopram and metabolites in adolescents.

Maternal use of antipsychotics in early pregnancy and delivery outcome.

Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy

Partial Compliance as Determined From Plasma Levels of Sertraline and Its Metabolite in Depressed Patients in Primary Care ⬇️

Sedative and hypnotic drugs—Fatal and non-fatal reference blood concentrations

Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression.

Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting.

Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.

The use of central nervous system active drugs during pregnancy

Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.

Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients

Therapeutic drug monitoring of sertraline: variability factors as displayed in a clinical setting

Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.